Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
15 December 2022Website:
http://www.gehealthcare.comNext earnings report:
N/ALast dividends:
18 October 2024Next dividends:
N/APrice
after hours | Fri, 01 Nov 2024 23:35:54 GMTAnalysts recommendations
Institutional Ownership
GEHC Latest News
GE HealthCare's separation from GE has created opportunities for each part of the company to grow on its own and target specific markets. In the third quarter, the company reported consistent revenue and profit increases, thanks to improved operations and rising demand for medical technologies. While GE HealthCare is set to benefit from developments in AI and diagnostics, it may experience some short-term challenges in China.
In the third quarter, GEHC saw a drop in revenue from its imaging and ultrasound segments, but this was balanced out by strong results in Pharmaceutical Diagnostics. Overall, profits increased due to improved pricing.
GE HealthCare Technologies Inc. (NASDAQ:GEHC) will hold its Q3 2024 Earnings Conference Call on October 30, 2024, at 8:30 AM ET. The call will feature company representatives, including Carolynne Borders, Peter Arduini, and Jay Saccaro, along with participants from various financial institutions. Thank you for joining us for this discussion on GE HealthCare's performance.
The financial results for GE HealthCare (GEHC) from the quarter ending in September 2024 provide insight into the company's performance. It may also be helpful to compare some important metrics with Wall Street predictions and figures from the same period last year.
GE HealthCare (GEHC) announced that its profits for the third quarter were higher than anticipated, while its sales were about what analysts had predicted.
GE HealthCare Technologies (GEHC) reported quarterly earnings of $1.14 per share, which is higher than the Zacks Consensus Estimate of $1.06 per share. This is an increase compared to last year's earnings of $0.99 per share.
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has announced its financial results for the third quarter that ended on September 30, 2024. Peter Arduini, the President and CEO of GE HealthCare, mentioned that the company experienced a 1% increase in global sales and orders during this quarter. Excluding China, sales and orders grew in the mid-single digits, with strong performance noted in the U.S. across all segments, particularly in Pharmaceutical Diagnostics due to high procedure volumes.
Investors looking at Medical Info Systems stocks probably know about Definitive Healthcare Corp. (DH) and GE HealthCare Technologies (GEHC). However, which of these two stocks offers a better value opportunity for investors at this moment?
GEHC's results for the third quarter are expected to show a drop in revenue from imaging, ultrasound, and patient care segments. However, the overall profit may improve due to better pricing strategies.
GE HealthCare (GEHC) will announce its earnings on Wednesday morning, and experts expect both revenue and profits to increase compared to the same period last year.
What type of business is GE HealthCare Technologies?
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
What sector is GE HealthCare Technologies in?
GE HealthCare Technologies is in the Healthcare sector
What industry is GE HealthCare Technologies in?
GE HealthCare Technologies is in the Health Information Services industry
What country is GE HealthCare Technologies from?
GE HealthCare Technologies is headquartered in United States
When did GE HealthCare Technologies go public?
GE HealthCare Technologies initial public offering (IPO) was on 15 December 2022
What is GE HealthCare Technologies website?
https://www.gehealthcare.com
Is GE HealthCare Technologies in the S&P 500?
Yes, GE HealthCare Technologies is included in the S&P 500 index
Is GE HealthCare Technologies in the NASDAQ 100?
Yes, GE HealthCare Technologies is included in the NASDAQ 100 index
Is GE HealthCare Technologies in the Dow Jones?
No, GE HealthCare Technologies is not included in the Dow Jones index
When was GE HealthCare Technologies the previous earnings report?
No data
When does GE HealthCare Technologies earnings report?
Next earnings report date is not announced yet